Adverse event data from the treatment arm of the CORTIS-01 trial
Domain:
healthcareRecord type:
dataset
Creator:
ThoMarHum
Publisher:
Uni
Host:
Adverse event data from the treatment arm of the CORTIS-01 trial. 20,207 volunteers were screened at five geographically diverse sites across South Africa. RISK11 signature scores were measured by microfluidic RT-qPCR on mRNA derived from whole blood collected in PAXgene tubes. Participants were randomised into three groups and followed-up for 15 months to evaluate diagnostic and prognostic performance of RISK11 and to evaluate efficacy of high-dose isoniazid and rifapentine for prevention of incident TB. Data from the trial are available here: doi.org current dataset includes adverse event data from the treatment group (375 participants), who received rifapentine and isozianid once-weekly, directly-observed, open-label isoniazid and rifapentine for 12 weeks.
Similar
Data from: The consequences of an introgression event<p>Adverse event assessment.</p><p>Adverse event assessment, detailed.</p>Battaliŋ - Traditional trial 01 0113-Battaliŋ - Traditional trial 01 The system of nominal classification in Gujjolay EegimaImplementation of data triangulation and dashboard development for COVID-19 vaccine adverse event following immunisation (AEFI) data in NigeriaExperimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial IDDO_EORKWS